Korea Food Research Institute

Hee Soon Shin

So-Young Lee

Young-Do Nam

Jae-Goo Kim

Eun-Yeong Lim

Yun-Tai Kim

So Young Lee

Eun Sook Lee

Yong-Soo Park

Eun-Ji Song

Young Do Nam

So Lim Park

Dong Uk Shin

Won Hyong Chung

Sun Young Jung

Seung Yong Kim

Eun Ji Song

Ji Eun Eom

Dae Woon Choi

Mi Young Lim

Jisu Kang

Ji-Hee Shin

Seungpyo Hong

Won-Hyong Chung

The present invention relates to a food composition for enhancing respiratory function and improving respiratory diseases, usingKF511 strain; a health functional food comprising the food composition; and a pharmaceutical composition for preventing or treating the respiratory diseases, comprisingstrain, its culture solution, its concentrate, or its dried product, as an active ingredient.

Composition for improving respiratory diseases using Lactobacillus plantarum strain

The present invention relates to: a novelYT2 strain (deposition number: KCCM11812P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient,comprising the novel strain. The present inventors have established an animal model for menopause through ovariectomy, confirmed changes of the distribution of intestinal microorganisms by the model, identified and isolated a novelstrain among lactic acid bacteria of which the distribution is significantly reduced in the menopausal model, and confirmed effects, by means of the novel strain and previously reportedstrains, of alleviating menopausal symptoms, such as the inhibition of an increase in body fat, the inhibition of a decrease in bone mineral density, the inhibition of an increase in the pain sensitivity, and the alleviation of depression. Therefore, it is expected that the composition comprising theaccording to the present invention can be usable for a use of preventing, alleviating, or treating menopause.

Composition for preventing or treating menopause, containing

A novelAO356 strain according to the present disclosure, which is a strain isolated from the human body, has high stability, exhibits the activity of inhibiting adipogenic differentiation in vitro and inducing the differentiation of M1 and M0 macrophages into M2 macrophages, and has excellent activity of alleviating, preventing, or treating obesity, such as the activity of reducing body weight and a reduction in blood lipid concentration through the browning of white fat in animal experiments. Thus, the novel strain of the present disclosure has a low possibility of causing side effects, and therefore, unlike conventional diet functional foods or drugs, which have side effect problems, a diet effect can be exhibited without controlling the dose thereof. Accordingly, the novel strain can be used as a pharmaceutical composition for treating or preventing obesity or a food composition for alleviating or preventing obesity.

AO356 strain having anti-obesity activity and method for preventing, alleviating or treating obesity using the same

Provided is a novelYTI strain (deposition number: KCCM 11808P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient,comprising the novel strain.

Growing community of inventors

Gyeonggi-do, South Korea

Hee Soon Shin